The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Evaluation of bleeding risk between apixaban and rivaroxaban in patients with gastrointestinal cancer.

Parker  Gundersen

No Relationships to Disclose

Alexa  Basilio

Consulting or Advisory Role - Premier Applied Sciences

Amber  Draper

Speakers' Bureau - Clinical Care Options/NCCN

Emily  Tiao

Consulting or Advisory Role - GlaxoSmithKline

Marin Ibrahim  Abousaud

Employment - Astellas Pharma

Olumide B.  Gbolahan

Stock and Other Ownership Interests  - Pfizer

Consulting or Advisory Role - Exelixis; Incyte; Merck Sharp & Dohme; QED Therapeutics

Speakers' Bureau - OncLive/MJH Life Sciences

Research Funding - Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Eisai (Inst); Pfizer (Inst); Zymeworks (Inst)